ADIPOQ and hepatocellular carcinoma: Third, we need prospective cohort studies to clarify whether baseline circulating adiponectin and/or hepatic (in HCC and the adjacent non-cancerous tissue) adiponectin may serve as positive or negative predictors of the survival in NAFLD-associated HCC.